EVEN BETTER CLINICAL ACNE SOLUTIONS- salicylic acid liquid 
CLINIQUE LABORATORIES LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

EVEN BETTER CLINICAL ACNE SOLUTIONS

Active Ingredients

SALICYLIC ACID 0.5%

Purpose

Acne treatment

USE

for the management of acne

treats acne

clears acne blemishes

helps prevent development of new acne blemishes

Warnings

For external use only


When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If this occurs, use only one topical acne medication at a time.


Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

cleanse skin thoroughly before applying
if bothersome dryness or peeling occurs, reduce application to every other day

Inactive ingredients

water\aqua\eau· methyl lrimethicone· nylon-12· butylene glycol · aloohol denat.· peg-10 dimelhicme ·dimelhioone· silica· trimelhylsiloxysilicale · hamamelis virginiana(witchhazel) water · trnhalose·calcium stearate · zinc r:ca · algae extract · lactobacillusferment·laminaria saccharina extract·glycyrrhetinicacid · glycerin· caffeine·dimethicone/vinyl dimethiconeCflliSilllymer· melhioone ·lauryl peg-9 polydimethylsiloxyethyl dimethicone ·isohexadecane ·10-hyoroxydecanoic acid· dimethicone/ peg-10/15 crosspolymer· sodium chloride· dipropylene glycol· tromethamine · lecithin·sorbitan sesquioleate · propylene cartrnate· disteardimonium hectonte · tocopherol· sodium citrate· diso:Jiumedta· phenoxyethanol · oonzoicacid· potassium sorbate · [+/-mica· titaniumdioxide(ci 77891) · ironoxides(ci 77492) · iron oxides (ci 77491) · iron oxides (ci 77499)] [iln99668]

PRINCIPAL DISPLAY PANEL

CLINIQUE
acne solutions
liquid makeup
SALICYLIC ACID ACNE TREATMENT

1 FL.OZ.LIQ./30ml

99668

EVEN BETTER CLINICAL ACNE SOLUTIONS 
salicylic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49527-114
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID5 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
METHYL TRIMETHICONE (UNII: S73ZQI0GXM)  
ALCOHOL (UNII: 3K9958V90M)  
TREHALOSE (UNII: B8WCK70T7I)  
CALCIUM STEARATE (UNII: 776XM7047L)  
ZINC PIDOLATE (UNII: C32PQ86DH4)  
LIMOSILACTOBACILLUS REUTERI (UNII: 9913I24QEE)  
CAFFEINE (UNII: 3G6A5W338E)  
ISOHEXADECANE (UNII: 918X1OUF1E)  
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
SACCHARINA LATISSIMA (UNII: 68CMP2MB55)  
10-HYDROXYDECANOIC ACID (UNII: NP03XO416B)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
PROPYLENE CARBONATE (UNII: 8D08K3S51E)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
MICA (UNII: V8A1AW0880)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
SORBITAN SESQUIOLEATE (UNII: 0W8RRI5W5A)  
NYLON-12 (UNII: 446U8J075B)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)  
HAMAMELIS VIRGINIANA TOP WATER (UNII: NT00Y05A2V)  
PORPHYRIDIUM PURPUREUM (UNII: K2P8K2558N)  
ENOXOLONE (UNII: P540XA09DR)  
GLYCERIN (UNII: PDC6A3C0OX)  
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (HARD PARTICLE) (UNII: H895X08VNQ)  
METHICONE (20 CST) (UNII: 6777U11MKT)  
LAURYL PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: 25G622K2RA)  
DIMETHICONE/PEG-10/15 CROSSPOLYMER (UNII: 21AS8B1BSS)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
TROMETHAMINE (UNII: 023C2WHX2V)  
TOCOPHEROL (UNII: R0ZB2556P8)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49527-114-011 in 1 CARTON09/08/2023
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM00609/08/2023
Labeler - CLINIQUE LABORATORIES LLC (044475127)
Registrant - Estee Lauder Companies Inc. (790802086)
Establishment
NameAddressID/FEIBusiness Operations
Estee Lauder N.V.370151326manufacture(49527-114) , label(49527-114) , pack(49527-114)

Revised: 9/2023
Document Id: 04dc3397-6030-da11-e063-6394a90aacea
Set id: 02e22431-ae2f-1f42-e063-6394a90aa3af
Version: 2
Effective Time: 20230908
 
CLINIQUE LABORATORIES LLC